相关实验视频
Updated: Mar 18, 2026
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
40.9K
假定背后的机制 脂蛋白 (a) 引起的动脉样硬化
Annalisa Filtz1, Leandro Slipczuk1, Martha Gulati2,3
1Cardiology Division, Montefiore Medical Center/Albert Einstein College of Medicine Bronx, NY, US.
European cardiology
|March 16, 2026
概括
脂蛋白 (Lp) 是心血管疾病的关键风险因素. 了解其在动脉样硬化发展和进展中的作用对于新疗法至关重要.
科学领域:
- 心血管生物学 心血管生物学
- 动脉样硬化研究 动脉样硬化研究
- 脂质代谢 脂质代谢是什么
背景情况:
- 脂蛋白 (Lp) 是动脉样硬化心血管疾病的既定,独立的风险因素.
- 通过Lp(a) 促进动脉动脉生成的确切机制仍在被阐明.
- Lp (a) 在动脉斑块的发展和进展中发挥着多方面的作用.
研究的目的:
- 审查和综合目前对脂蛋白在动脉动脉生成中的作用的理解.
- 突出通过Lp(a) 影响心血管疾病的生物机制.
- 强调Lp (a) 生物学对未来治疗策略的重要性.
主要方法:
- 关于脂蛋白 (Lp) 和动脉样硬化现有研究的文献综述.
- 分析证据支持Lp (a) 对内皮功能障碍,炎症和脂质保留的贡献.
- 检查Lp(a) 的前血栓效应和对纤维素分解的影响.
主要成果:
- Lp (a) 促进内皮功能障碍,血管炎症和动脉壁中的脂质积累.
- Lp (a) 驱动泡细胞的形成和光滑肌肉细胞的激活,是斑块发育的关键早期事件.
- Lp (a) 干扰纤维解质,增加血栓形成的风险和斑块破裂的可能性.
结论:
- 脂蛋白 (Lp) 通过多个相互连接的途径,对动脉样硬化的启动和进展作出重大贡献.
- 对于开发有效的临床治疗来说,对Lp (a) 生物学有一个全面的理解至关重要.
- 对Lp (a) 机制的进一步研究将有助于将新型疗法转化为临床实践.
相关概念视频
01:30Atherosclerosis I: Introduction
1.8K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
01:26Coronary Artery Disease II: Pathophysiology
894
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
894
01:38Inflammation
63.8K
Overview
63.8K
01:30Peripheral Artery Disease I: Introduction
568
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
568
01:26Atherosclerosis III: Management
567
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
01:30Coronary Artery Disease I: Introduction
1.5K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K